Adrenomed AG (private company)

See something wrong or missing? Let us know
Offices:Berlin
Business model:B2B

Adrenomed AG is a German clinical-stage biopharmaceutical company.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 26.86M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Adrenomed AG

Name Criteria
United Kingdom Achilles Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Biofidelity
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Immune Regulation
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France InnoSkel
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top